In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: STERIS plc’s current price is moderately below the PERT-weighted fair value, indicating potential undervaluation with a 7.8% implied upside. Monte Carlo analysis reveals high volatility and significant downside risk (55.6% scenarios below price), reflecting earnings uncertainty despite strong liquidity and leverage profiles. Growth prospects score low, dampening the valuation’s margin of safety.